These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1673626)

  • 1. Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose.
    Henderson RA; Lane S; Henry JA
    Hum Exp Toxicol; 1991 Jan; 10(1):59-62. PubMed ID: 1673626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review.
    Hunt N; Stern TA
    Psychosomatics; 1995; 36(6):541-9. PubMed ID: 7501784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of drug-induced torsades de pointes with overdrive pacing.
    Charlton NP; Lawrence DT; Brady WJ; Kirk MA; Holstege CP
    Am J Emerg Med; 2010 Jan; 28(1):95-102. PubMed ID: 20006210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.
    Rao KA; Adlakha A; Verma-Ansil B; Meloy TD; Stanton MS
    Mayo Clin Proc; 1994 Jun; 69(6):589-93. PubMed ID: 8189766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol-induced torsade de pointes.
    O'Brien JM; Rockwood RP; Suh KI
    Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
    van der Klauw MM; van Rey FJ; Stricker BH
    Ned Tijdschr Geneeskd; 1992 Jan; 136(2):91-3. PubMed ID: 1370730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.
    Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S
    Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide induced ventricular tachycardia (torsades de pointes).
    Thevenin J; Da Costa A; Roche F; Romeyer C; Messier M; Isaaz K
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1907-8. PubMed ID: 12930510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminology of torsades de pointes.
    Tzivoni D; Keren A; Banai S; Stern S
    Cardiovasc Drugs Ther; 1991 Apr; 5(2):505-7. PubMed ID: 1854659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable case of torsades de pointes induced by fluconazole.
    Khazan M; Mathis AS
    Pharmacotherapy; 2002 Dec; 22(12):1632-7. PubMed ID: 12495173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.